Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar
Open accessThe DOI matches its Crossref record; 74 of the 76 references it cites were found in a registry or an index; 6 of the 70 sources its claims cite were checked for support.
Abstract
Between October 2001 and April 2002, five cases of acute flaccid paralysis (AFP) associated with type 2 vaccine-derived polioviruses (VDPVs) were reported in the southern province of the Republic of Madagascar. To determine viral factors that favor the emergence of these pathogenic VDPVs, we analyzed in detail their genomic and phenotypic characteristics and compared them with co-circulating enteroviruses. These VDPVs appeared to belong to two independent recombinant lineages with sequences from the type 2 strain of the oral poliovaccine (OPV) in the 5'-half of the genome and sequences derived from unidentified species C enteroviruses (HEV-C) in the 3'-half. VDPV strains showed characteristics similar to those of wild neurovirulent viruses including neurovirulence in poliovirus-receptor transgenic mice. We looked for other VDPVs and for circulating enteroviruses in 316 stools collected from healthy children living in the small area where most of the AFP cases occurred. We found vaccine PVs, two VDPVs similar to those found in AFP cases, some echoviruses, and above all, many serotypes of coxsackie A viruses belonging to HEV-C, with substantial genetic diversity. Several coxsackie viruses A17 and A13 carried nucleotide sequences closely related to the 2C and the 3D(pol) coding regions of the VDPVs, respectively. There was also evidence of multiple genetic recombination events among the HEV-C resulting in numerous recombinant genotypes. This indicates that co-circulation of HEV-C and OPV strains is associated with evolution by recombination, resulting in unexpectedly extensive viral diversity in small human populations in some tropical regions. This probably contributed to the emergence of recombinant VDPVs. These findings give further insight into viral ecosystems and the evolutionary processes that shape viral biodiversity.
Overview
CoChat Summary
## TL;DR
Madagascar’s Tolagnaro district had two independently emerging type 2 vaccine-derived poliovirus (VDPV) lineages associated with five AFP cases from October 2001 to April 2002, and these viruses showed recombination with unidentified species C enteroviruses (HEV-C). In 316 stool samples from healthy children, the authors found continued circulation of similar VDPVs plus unusually high HEV-C diversity and many recombination events, suggesting a local viral ecosystem that favors poliovirus evolution.
## Key findings
- Five AFP cases were associated with type 2 VDPVs reported between October 2001 and April 2002; genome sequencing showed the isolates fell into two independent recombinant lineages: one centered on MAD 04 (with MAD 05–07) and one on MAD 29.
- The Madagascan VDPVs had Sabin 2-like 5′ halves and diverged 3′ halves derived from non-vaccine sequences; the inferred recombination sites were near nt 3,801 for MAD 04 and related strains and near nt 3,708 for MAD 29.
- In 316 stool specimens from healthy children, the study isolated 23 PVs and 71 other viruses; 68 non-polio viruses were identified as enteroviruses, and the authors found 64 enteroviruses by VP1 typing, including 51 HEV-C isolates: 12 CA11, 16 CA13, 8 CA17, 1 CA20, and 14 CA24.
- The authors inferred 19 HEV-C recombinant lineages from incongruences among phylogenetic trees; they also found that two VDPVs from healthy children clustered with the MAD 04/MAD 07 lineage, and they note that only 7% of children were excreting Sabin-like PVs two weeks after the second local vaccination round.
## Methods
- The study combined outbreak investigation and field sampling in the Tolagnaro district: stool samples from AFP cases and 316 stool specimens from healthy children collected during June 21–22 field investigations.
- Viruses were isolated in RD, HEp-2c, and L20B cells, then characterized by RT-PCR, full-genome or partial sequencing, molecular typing, restriction analysis, and neutralization assays.
- Genetic relationships were assessed with alignment and phylogenetic analysis of VP1, 2C, 3D, and 5′ UTR sequences using maximum likelihood and neighbor-joining approaches; phenotypes were tested for temperature sensitivity, plaque size, antigenic structure, and neurovirulence in PVR-Tg mice.
## Limitations
- The paper states that search for viral mixtures was not the primary goal, and the viral isolation procedures were poorly adapted to detect them; it also notes that about 25% of PV-positive samples may have contained another enterovirus serotype masked on L20B cells.
- The authors note that re-inoculation of cells with neutralizing antibodies was not performed to check for a second serotype in positive samples.
- Evident from the text: the field sample was limited to one district and 316 children, so the findings describe a localized ecosystem rather than broader prevalence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Phylogenetic Trees Depicting Genetic Relationships between Nucleotide Sequences of Enteroviruses of the HEV-C Species These neighbor-joining trees were based on nucleotide sequence alignments of part of the 5′ UTR, the C-terminal third of the VP1-coding regions, part of the 2C-coding regions, and of the 3Dpol regions. Branch lengths were calculated using PUZZLE and the Hasegawa, Kishino, and Yano (HKY) model of substitution [63]. The genetic distance is indicated (bar). Numbers at nodes correspond to the percentage of 25,000 puzzle steps supporting the distal cluster; numbers in italics representing the percentage of 1,000 bootstrap pseudoreplicates obtained with the DNADist/Neighbor and SEQBOOT programs of PHYLIP [65] are shown in several cases. Sequences of some of the last wild PV strains (PV3.Mad95, PV1.Mad96a, PV1.Mad96b, and PV3.Mad97) isolated in Madagascar (1995–1997) were used in addition to HEV-C prototype strains (CA1 to CA24). Selected PV strains isolated during the last poliomyelitis outbreak in Finland (PV3.Fin84) and during the recent VDPV outbreaks in Egypt (PV2.Egy93; PV2.Egy88), Haiti (PV1.Hai00), Dominican Republic (PV1.Dor00), and the Philippines (PV1.Phi01) are included. Sequences of the recombinant type 3 PV isolated from a poliomyelitis case in Cambodia in 2002 (PV3.Cam02) were also used. Nucleotide sequences of echovirus 70 (EV70) were used as outgroup. Identifiers of the HEV-C coxsackie A viruses isolated from healthy children in 2002 in Madagascar consist of the given serotype as assessed from partial sequencing [33] and the laboratory number. New VDPV isolates from healthy children are indicated with their laboratory numbers. Spots of different colors differentiate HEV-C serotypes and polioviruses (red). VDPVs from Madagascar are indicated by oblong spots. According to the Eight Report of the ICTV [56], former CA15 and CA18 are considered as antigenic variants of CA11 and CA13, and are now named CA11v and CA13v, respectively. All field isolates from Madagascar, except isolates CA24.65902 and CA24.68187, were sequenced in the four regions. Vertical dotted lines indicate groups of isolates of particular interest that are discussed in the text.](https://figures.cochat.ai/paper-figures/a17253f9018b477283b49e5c4d249ecf/co-circulation-and-evolution-of-polioviruses-and-species-c-enteroviruses-in-a-figure-4.jpg)
Verification
Claims the paper makes
4 Valid · 0 Not valid · 27 Not checked · 101 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Between October 2001 and April 2002, five cases of acute flaccid paralysis (AFP) associated with type 2 vaccine-derived polioviruses (VDPVs) were reported in the southern province of the Republic of Madagascar.”
- Also stated in: § Introduction · plain
“In Madagascar, type 2 recombinant VDPVs were identified as the causative agent of five cases of poliomyelitis that occurred from October 2001 to April 2002 [14].”
§ Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar > Abstract Between October 2001 and April 2002, five cases of acute flaccid paralysis (AFP) associated with type 2 vaccine-derived polioviruses (VDPVs) were reported in the southern province of the Republic of Madagascar. To determine viral factors that favor the emergence of these pathogenic VDPVs, we analyzed in detail their genomic and phenotypic characteristics and compared them with co-circulating enteroviruses. These VDPVs appeared to belong to two independent recombinant lineages with sequences from the type 2 strain of the oral poliovaccine (OPV) in the 5′-half of the genome and sequences derived from unidentified species C enteroviruses (HEV-C) in the 3′-half. VDPV strains showed characteristics similar to those of wild neurovirulent viruses including neurovirulence in poliovirus-receptor transgenic mice. We looked for other VDPVs and for circulating enteroviruses in 316 stools collected from healthy children living in the small area where most of the AFP cases occurred. We found vaccine PVs, two VDPVs similar to those found in AFP cases, some echoviruses, and above all, many serotypes of coxsackie A viruses belonging to HEV-C, with substantial genetic diversity. Several coxsackie viruses A17 and A13 carried nucleotide sequences closely related to the 2C and the 3Dpol coding regions of the VDPVs, respectively. There was also evidence of multiple genetic recombination events among the HEV-C resulting in numerous recombinant genotypes. This indicates that co-circulation of HEV-C and OPV strains is associated with evolution by recombination, resulting in unexpectedly extensive viral diversity in small human populations in some tropical regions. This probably contributed to the emergence of recombinant VDPVs. These findings give further insight into viral ecosystems and the evolutionary processes that shape viral biodiversity.
What the sources say
- Supportedcites [14] 2003, Recombinant vaccine-derived poliovirus in Madagascar., Emerg Infect Dis source
The opening paragraph of “Recombinant Vaccine–Derived Poliovirus in Madagascar” states the same dates, number of acute flaccid paralysis cases, type 2 vaccine-derived poliovirus association, and location as the citing sentence. (LLM, conf=0.95)
plainstates an associationn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“In particular, from the analysis of similar recombinant type 2 VDPVs circulating in Egypt, the evolution rate of the capsid VP1 region appeared to be 2.5 (± 0.7).10−2 substitutions per synonymous site and per year [18].”
§ Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar > Results > Sequence Analysis of the Madagascan VDPV Genomes
What the sources say
- Supportedcites [18] 2003, Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993., J Virol source
The RESULTS section ('Estimated time of occurrence of initiating OPV dose', p. ~7) states the VP1 evolution rate from the regression slope as (2.47 ± 0.69) × 10−2 substitutions per synonymous site per year, which the citing sentence rounds to 2.5 (± 0.7) × 10−2. The same passage ties this to the Egyptian type 2 cVDPV isolates (1988–1993), and the Abstract/DISCUSSION confirm these isolates are recombinants with other species C enteroviruses, matching 'similar recombinant type 2 VDPVs circulating in Egypt'. (LLM, conf=0.95)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Most VDPV strains described as OPV/HEV-C recombinants were isolated in countries in which wild PVs have been eradicated”
§ Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar > Discussion
What the sources say
- Not checked yetcites [11] 2004, Circulating vaccine-derived polioviruses: current state of knowledge., Bull World Health Organ
- Not checked yetcites [12] 2002, Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus., Science source
- Partly supportedcites [14] 2003, Recombinant vaccine-derived poliovirus in Madagascar., Emerg Infect Dis sourceExperimental — accuracy not yet measured
The paper reports OPV/cluster C recombinant VDPVs in Madagascar and says no wild poliovirus strains had been isolated there since 1997 (main text; page unavailable). It also mentions similar recombinants in Hispaniola and the Philippines, but does not establish that wild poliovirus had been eradicated in those countries or that most such strains came from countries where it had been eradicated. (LLM, conf=0.82)
- Not checked yetcites [15] 2004, Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001., J Virol source
- Not checked yetcites [16] WHO, 2006, Vaccine-derived polioviruses: update., Wkly Epidemiol Rec
- Partly supportedcites [18] 2003, Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993., J Virol sourceExperimental — accuracy not yet measured
The Discussion says all outbreak-associated cVDPV isolates described at the time were recombinants with species C enteroviruses, and it links cVDPV emergence to elimination of competing wild polioviruses. But the claim overstates the eradication point: the paper describes elimination of the corresponding wild-poliovirus serotype, not all wild polioviruses in those countries; it says wild types 1 and 3 continued circulating in Egypt. (LLM, conf=0.88)
- Not checked yetcites [20] WHO, 2001, Transmission of wild poliovirus type 2-apparent global interruption., Wkly Epidemiol Rec
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“According to the sequence alignments presented in Figure 2, the likely sites of recombination in the genome of MAD 04 and other VDPV strains isolated in 2002 (MAD 05 to MAD 07) were all close to nt 3,801 (codon 139 of 2A).”
§ Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar > Results > Sequence Analysis of the Madagascan VDPV Genomes
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These VDPVs appeared to belong to two independent recombinant lineages with sequences from the type 2 strain of the oral poliovaccine (OPV) in the 5′-half of the genome and sequences derived from unidentified species C enteroviruses (HEV-C) in the 3′-half.”
§ Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar > Abstract Between October 2001 and April 2002, five cases of acute flaccid paralysis (AFP) associated with type 2 vaccine-derived polioviruses (VDPVs) were reported in the southern province of the Republic of Madagascar. To determine viral factors that favor the emergence of these pathogenic VDPVs, we analyzed in detail their genomic and phenotypic characteristics and compared them with co-circulating enteroviruses. These VDPVs appeared to belong to two independent recombinant lineages with sequences from the type 2 strain of the oral poliovaccine (OPV) in the 5′-half of the genome and sequences derived from unidentified species C enteroviruses (HEV-C) in the 3′-half. VDPV strains showed characteristics similar to those of wild neurovirulent viruses including neurovirulence in poliovirus-receptor transgenic mice. We looked for other VDPVs and for circulating enteroviruses in 316 stools collected from healthy children living in the small area where most of the AFP cases occurred. We found vaccine PVs, two VDPVs similar to those found in AFP cases, some echoviruses, and above all, many serotypes of coxsackie A viruses belonging to HEV-C, with substantial genetic diversity. Several coxsackie viruses A17 and A13 carried nucleotide sequences closely related to the 2C and the 3Dpol coding regions of the VDPVs, respectively. There was also evidence of multiple genetic recombination events among the HEV-C resulting in numerous recombinant genotypes. This indicates that co-circulation of HEV-C and OPV strains is associated with evolution by recombination, resulting in unexpectedly extensive viral diversity in small human populations in some tropical regions. This probably contributed to the emergence of recombinant VDPVs. These findings give further insight into viral ecosystems and the evolutionary processes that shape viral biodiversity.
hedgedn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
72 more claims
Create a free account to see all 132 claims and to verify the 64 references still open.
- Probably not a substantial claim. 22
- It may state two separate claims as one. 42
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The genomes of these VDPVs belong to several independent, complex mosaic recombinant lineages composed of sequences derived from vaccine polioviruses and other co-circulating species C human enteroviruses (human EV-C) (4,5).”
From Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar (2013) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These VDPVs were found in patients with acute flaccid paralysis (AFP) and in healthy children who were contacts of the patients with AFP (2,4).”
From Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar (2013) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“All recombinant cVDPV genomes described so far had kept at least the entire region encoding the capsid proteins of OPV strains (with more than 1% nt substitutions), and some or all of the rest of the genome, particularly the region encoding non-structural proteins, originates from other HEV-Cs [67,83,84,88–90].”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [88]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most of them showed the 3′-half of their genome derived from non-OPV sequences with recombination sites located in proteins 2A or 2B [67,83,84,88].”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [88]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most of the cVDPVs that have been described so far share phenotypic characteristics including the capacity to induce poliomyelitis in humans and in transgenic mice expressing CD155, the human cellular receptor for PV [67,83,84,88].”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [88]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617 · cited 2×
“A fragment of 299 to 322 bp corresponding to the 3 9 third of VP1 capsid was compared with the corresponding region of available prototype sequences, using the CLUSTAL W alignment program [59].”
MethodThompson, J. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.24.4876 · Cited by 38,993
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926 · cited 2×
“Inoculated mice were monitored for 21 days and the PD50 was calculated by the method of Reed and Muench [ 68 ].”
MethodPHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227 · cited 1×
“The GenBank database was also screened for similar sequences using the FASTA program [60].”
MethodTree View: An application to display phylogenetic trees on personal computers
Page, R. D. M. (1996) · Bioinformatics · doi:10.1093/bioinformatics/12.4.357 · Cited by 10,178 · cited 1×
“Trees were drawn with the TREEVIEW [66] or NJ Plot programs [67].”
MethodDating of the human–ape splitting by a molecular clock of mitochondrial DNA.
Hasegawa, M., Kishino, H., & Yano, T.-A. (1985) · Journal of Molecular Evolution · doi:10.1007/bf02101694 · Cited by 8,687 · cited 1×
“The Hasegawa, Kishino, and Yano (HKY) model of substitution for nt with a Ts/Tv of 8.0 was used [64].”
MethodInfluentialLole, K. S., Bollinger, R. C., Paranjape, R. S., Gadkari, D., Kulkarni, S. S., Novak, N. G., Ingersoll, R., Sheppard, H. W., & Ray, S. C. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.152-160.1999 · Cited by 2,695 · cited 1×
“Complete genome sequences were compared following alignments with the plot-similarity program of GCG version 10.1 software (Genetics Computer Group, Madison, Wisconsin), using a 50-nt sliding window and the default scoring matrix [62].”
MethodInfluentialQuartet Puzzling: A Quartet Maximum-Likelihood Method for Reconstructing Tree Topologies
Strimmer, K., & von Haeseler, A. (1996) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a025664 · Cited by 2,531 · cited 1×
“regions. Branch lengths were calculated using PUZZLE and the Hasegawa, Kishino, and Yano (HKY) model of substitution [”
MethodWWW-query: An on-line retrieval system for biological sequence banks
Perrière, G., & Gouy, M. (1996) · Biochimie · doi:10.1016/0300-9084(96)84768-7 · Cited by 1,480 · cited 1×
“Trees were drawn with the TREEVIEW [66] or NJ Plot programs [67].”
Method
Research works printed but not linked: 2
- StanwayGBrownFChristianPHoviTHyypiäT 2005 Family Picornaviridae. In: FauquetCMMayoMAManiloffJDesselbergerUBallLA Virus taxonomy: eighth report of the international committee on taxonomy of viruses London Elsevier/Academic Press 757 778
- 1938, A simple method for estimating fifty percent endpoints., Amer J Hyg, 27, 493
Cited by
Combelas, N., Holmblat, B., Joffret, M.-L., Colbère-Garapin, F., & Delpeyroux, F. (2011) · Viruses · doi:10.3390/v3081460 · Cited by 135
“Most of them showed the 3'-half of their genome derived from non-OPV sequences with recombination sites located in proteins 2A or 2B [67,83,84,88].”
BackgroundSelf-citationYozwiak, N. L., Skewes-Cox, P., Gordon, A., Saborio, S., Kuan, G., Balmaseda, A., Ganem, D., Harris, E., & DeRisi, J. L. (2010) · Journal of Virology · doi:10.1128/jvi.00698-10 · Cited by 130
Recombination in Enteroviruses, a Multi-Step Modular Evolutionary Process
Muslin, C., Kain, A. M., Bessaud, M., Blondel, B., & Delpeyroux, F. (2019) · Viruses · doi:10.3390/v11090859 · Cited by 142
“Thus, the multiplication and circulation of OPV strains in close interaction with other EV-Cs within a diverse EV ecosystem led to exchanges of genetic fragments through intertypic recombination and the emergence of these cVDPV strains [65,70,86].”
BackgroundInfluentialSelf-citationJegouic, S., Joffret, M.-L., Blanchard, C., Riquet, F. B., Perret, C., Pelletier, I., Colbere-Garapin, F., Rakoto-Andrianarivelo, M., & Delpeyroux, F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000412 · Cited by 116
“The 2C sequences of a CA20 isolate from Tolagnaro were previously found to be related to those of MAD04 [27].”
BackgroundResultInfluentialSelf-citationHu, Y., Yang, F., Du, J., Dong, J., Zhang, T., Wú, Z., Xue, Y., & Jin, Q. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00007-11 · Cited by 119
“Ten outbreaks of poliomyelitis caused by pathogenic circulating vaccine-derived polioviruses (cVDPVs) have been reported so far, and most cVDPVs were recombinants of vaccine strains and other cocirculating HEV-C viruses, such as CVA13 and CVA17 (14, 36).”
BackgroundHigh Frequency and Diversity of Species C Enteroviruses in Cameroon and Neighboring Countries
Sadeuh-Mba, S. A., Bessaud, M., Massenet, D., Joffret, M.-L., Endegue, M.-C., Njouom, R., Reynes, J.-M., Rousset, D., & Delpeyroux, F. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02119-12 · Cited by 108
“The data from cVDPV outbreak studies in Cambodia and Madagascar have shown that CVA-13 and -17 are efficient recombination partners for PVs (3, 5, 13).”
BackgroundSelf-citationHuang, T., Wang, W., Bessaud, M., Ren, P., Sheng, J., Yan, H., Zhang, J., Lin, X., Wang, Y., Delpeyroux, F., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006355 · Cited by 110
“The genome of HEVs is subject to frequent recombination [30,31,32,33,34,35,36], with interspecies exchanges observed in the 59UTR [37].”
BackgroundSelf-citationDunn, G., Klapsa, D., Wilton, T., Stone, L., Minor, P. D., & Martin, J. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005114 · Cited by 106
“A cVDPV strain fromMadagascar [21] also reacted with most monoclonal antibodies.”
BackgroundTebbens, R. J. D., Pallansch, M. A., Kim, J., Burns, C. C., Kew, O. M., Oberste, M. S., Diop, O. M., Wassilak, S. G. F., Cochi, S. L., & Thompson, K. M. (2013) · Risk Analysis · doi:10.1111/risa.12022 · Cited by 105
“0) (56, 128, 132, 144) 2001 Syria 2 1 February 19, 2001 1–3 3 (1.”
Self-citationReemergence of recombinant vaccine–derived poliovirus outbreak in Madagascar.
Rakoto‐Andrianarivelo, M., Gumede, N., Jegouic, S., Balanant, J., Andriamamonjy, S. N., Rabemanantsoa, S., Birmingham, M., Randriamanalina, B., Nkolomoni, L., Venter, M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587694 · Cited by 100
“during the last 2001–2002 outbreaks [29] and during the present”
BackgroundSelf-citationBessaud, M., Pillet, S., Ibrahim, W., Joffret, M., Pozzetto, B., Delpeyroux, F., & Gouandjika‐Vasilache, I. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06657-11 · Cited by 105
“isolated in previous studies in Madagascar (49, 51).”
BackgroundResultInfluentialSelf-citationBrown, B. A., Maher, K., Flemister, M. R., Naraghi‐Arani, P., Uddin, M., Oberste, M. S., & Pallansch, M. A. (2009) · Journal of General Virology · doi:10.1099/vir.0.008540-0 · Cited by 111
Picornavirus non-structural proteins as targets for new anti-virals with broad activity
Norder, H., Palma, A. M. D., Selisko, B., Costenaro, L., Papageorgiou, N., Arnan, C., Coutard, B., Lantez, V., de Lamballerie, X. N., Baronti, C., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2010.12.007 · Cited by 89
Muslin, C., Joffret, M., Pelletier, I., Blondel, B., & Delpeyroux, F. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005266 · Cited by 86
“68143 strain were isolated in 2002 from stools of healthy children living in the district of Tolagnaro and grown in HEp-2c cells [29].”
BackgroundMethodInfluentialSelf-citationPliaka, V., Kyriakopoulou, Z., & Markoulatos, P. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.28 · Cited by 85
The final stages of the global eradication of poliomyelitis
Grassly, N. C. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0140 · Cited by 80
“At the time of writing 20 cVDPV had been reported from 20 different countries, the vast majority derived from the serotype 2 Sabin strain [91] and many recombinants with other human enteroviruses [92,93].”
BackgroundMechanisms of genetic variation in polioviruses
Savolainen‐Kopra, C., & Blomqvist, S. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.663 · Cited by 67
Nikolaidis, M., Mimouli, K., Kyriakopoulou, Z., Tsimpidis, M., Tsakogiannis, D., Markoulatos, P., & Amoutzias, G. D. (2018) · Virology · doi:10.1016/j.virol.2018.10.006 · Cited by 67
Describing the Silent Human Virome with an Emphasis on Giant Viruses
Popgeorgiev, N., Temmam, S., Raoult, D., & Desnues, C. (2013) · Intervirology · doi:10.1159/000354561 · Cited by 72
Holmblat, B., Jégouic, S., Muslin, C., Blondel, B., Joffret, M., & Delpeyroux, F. (2014) · mBio · doi:10.1128/mbio.01119-14 · Cited by 62
“We found that these strains were recombinant PV/CAV that had emerged from an HEV-C viral ecosystem with an unexpectedly high level of diversity, evolving through intra- and intertypic recombination (19, 22, 23).”
BackgroundSelf-citationThe 2010 outbreak of poliomyelitis in Tajikistan: epidemiology and lessons learnt
Yakovenko, M. L., Gmyl, A. P., Ivanova, O. E., Eremeeva, T. P., Ap, I., Prostova, M. A., Baykova, O. Y., Isaeva, O. V., Lipskaya, G. Y., Shakaryan, A. K., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.7.20706 · Cited by 60
“Epidemiological relevance of recombinants between wild polioviruses and other enteroviruses Recombination between WPV or vaccine-derived polioviruses with other enteroviruses C is well known [29-31], but its biological relevance remains unclear.”
Self-citationGenetic Relationship between Cocirculating Human Enteroviruses Species C
Bessaud, M., Joffret, M.-L., Holmblat, B., Razafindratsimandresy, R., & Delpeyroux, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024823 · Cited by 55
“was a field isolate genetically related to MAD004 [14,35].”
BackgroundMethodInfluentialSelf-citationApostol, L. N. G., Suzuki, A. K., Bautista, A., Galang, H. O., Paladin, F. J., Fuji, N., Lupisan, S., Olveda, R. M., & Oshitani, H. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23242 · Cited by 58
The Golgi Protein ACBD3, an Interactor for Poliovirus Protein 3A, Modulates Poliovirus Replication
Téoulé, F., Brisac, C., Pelletier, I., Vidalain, P., Jégouic, S., Mirabelli, C., Bessaud, M., Combelas, N., Autret, A., Tangy, F., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00304-13 · Cited by 52
“In most of the genomes of the PVS2-derived cVDPVs responsible for polio outbreaks in Madagascar, the region encoding nonstructural protein 3A is related to that of field CV-A17 strains (5, 8).”
BackgroundInfluentialSelf-citationProbing the Flavivirus Membrane Fusion Mechanism by Using Monoclonal Antibodies
Stiasny, K., Brandler, S., Kössl, C., & Heinz, F. X. (2007) · Journal of Virology · doi:10.1128/jvi.01041-07 · Cited by 49
Bessaud, M., Joffret, M., Blondel, B., & Delpeyroux, F. (2016) · Scientific Reports · doi:10.1038/srep38831 · Cited by 53
Self-citationMueller, J. E., Bessaud, M., Huang, Q. S., Martínez, L. C., Barril, P. A., Morel, V., Balanant, J., Bocacao, J., Hewitt, J., Gessner, B. D., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.02201-08 · Cited by 48
Self-citationJoffret, M.-L., Jégouic, S., Bessaud, M., Balanant, J., Tran, C., Caro, V., Holmblat, B., Razafindratsimandresy, R., Reynes, J.-M., Rakoto-Andrianarivelo, M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis204 · Cited by 44
“V2-MAD04–V2-MAD07 and V2-MAD29 are type 2 VDPVs isolated in Madagascar in 2001–2002 [2].”
BackgroundResultInfluentialSelf-citationBailly, J., Mirand, A., Henquell, C., Archimbaud, C., Chambon, M., Regagnon, C., Charbonné, F., & Peigue‐Lafeuille, H. (2010) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2010.06.019 · Cited by 48
Global landscape of coxsackieviruses in human health
Machado, R. S., Tavares, F. N., & Junior, I. P. D. S. (2024) · Virus Research · doi:10.1016/j.virusres.2024.199367 · Cited by 43
Bessaud, M., Jégouic, S., Joffret, M., Barge, C., Balanant, J., Gouandjika‐Vasilache, I., & Delpeyroux, F. (2008) · Journal of Virological Methods · doi:10.1016/j.jviromet.2008.01.027 · Cited by 42
“, 1999), leading to a wide range of mosaic genomes inside human enterovirus species (Chen et al., 2007; Lukashev et al., 2003; Oberste et al., 2004; Rakoto-Andrianarivelo et al., 2007; Simmonds and Welch, 2006).”
BackgroundSelf-citationJunior, I. P. D. S., Oliveira, M. D. L. A., Burlandy, F. M., Machado, R. S., Oliveira, S. S., Tavares, F. N., Gomes‐Neto, F., da Costa, E. V., & da Silva, E. E. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1850181 · Cited by 35
“diversity, due to cumulative mutations and/or recombinations [4,5].”
BackgroundBessaud, M., Sadeuh‐Mba, S. A., Joffret, M., Razafindratsimandresy, R., Polston, P. M., Volle, R., Andrianarivelo, M. R., Blondel, B., Njouom, R., & Delpeyroux, F. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01294 · Cited by 32
Self-citationRiquet, F. B., Blanchard, C., Jegouic, S., Balanant, J., Guillot, S., Vibet, M.-A., Rakoto-Andrianarivelo, M., & Delpeyroux, F. (2008) · Journal of Virology · doi:10.1128/jvi.00239-08 · Cited by 29
“Genetic analyses of recombinant cVDPV strains and cocirculating enteroviruses have recently shown that HEV-C isolates (coxsackievirus strains A13 and A17) exhibit highest similarity with these cVDPVs in the genomic regions encoding the nonstructural proteins and in the 3 UTR (3, 26).”
BackgroundMethodSelf-citationYakovenko, M. L., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Samoilovich, E., Uhova, I., Gavrilin, G. V., & Agol, V. I. (2009) · Journal of Virology · doi:10.1128/jvi.02122-08 · Cited by 29
“Indeed, such VDPV have also been detected by others (19, 20, 26), though they did not appear to attract special attention.”
BackgroundAdeniji, J. A., & Faleye, T. O. C. (2015) · Archives of Virology · doi:10.1007/s00705-014-2322-x · Cited by 29
“The contribution of CVA13s to the emergence of cVDPVs have been documented [17, 18, 22].”
Equine picornaviruses: Well known but poorly understood
Horsington, J. J., Lynch, S. E., Gilkerson, J. R., Studdert, M. J., & Hartley, C. A. (2013) · Veterinary Microbiology · doi:10.1016/j.vetmic.2013.05.012 · Cited by 27
Zhang, Y., Wang, H., Zhu, S., Li, Y., Li, S., Liu, Y., Liu, G., Nishimura, Y., Chen, L., Yan, D., et al. (2009) · Journal of General Virology · doi:10.1099/vir.0.014258-0 · Cited by 26
“The amino acid sequences within or near the predicted neutralizing antigenic (NAg) sites (Minor, 1990) were aligned with the penta-recombinant VDPV, Sabin 2 strain, two Egypt type 2 cVDPV strains (GenBank accession nos AF448782 and AF448783) (Yang et al., 2003), two Madagascar type 2 cVDPV strains (GenBank accession n…”
BackgroundZhang, Y., Yan, D., Zhu, S., Nishimura, Y., Ye, X., Wang, D., Jorba, J. C., Zhu, H., An, H., Shimizu, H., et al. (2015) · Scientific Reports · doi:10.1038/srep17291 · Cited by 25
Self-citationJunior, I. P. D. S., GIAMBERARDINO, H. I. G., Raboni, S. M., Debur, M. C., Oliveira, M. D. L. A., Burlandy, F. M., & da Silva, E. E. (2021) · Virology Journal · doi:10.1186/s12985-021-01560-w · Cited by 25
High frequency and diversity of parechovirus A in a cohort of Malawian children
Brouwer, L., Karelehto, E., Han, A. X., Thomas, X. V., Bruning, A. H. L., Calis, J. C. J., van Hensbroek, M. B., Westerhuis, B. M., Amarthalingam, D., Koekkoek, S. M., et al. (2019) · Archives of Virology · doi:10.1007/s00705-018-04131-7 · Cited by 27
Korotkova, E. A., Gmyl, A. P., Yakovenko, M. L., Ivanova, O. E., Eremeeva, T. P., Kozlovskaya, L. I., Shakaryan, A. K., Lipskaya, G. Y., Parshina, I. L., Loginovskikh, N. V., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00277-16 · Cited by 23
“This work was funded by Russian Science Foundation (RSF) (15-1500147).”
MethodZhang, Y., Sun, Q., Cui, H., Yan, D., Fan, Q., Song, Y., Zhu, S., Li, X., Huang, G., Ji, T., et al. (2016) · Scientific Reports · doi:10.1038/srep33595 · Cited by 24
Brouwer, L., van der Sanden, S. M. G., Calis, J. C. J., Bruning, A. H. L., Wang, S., Wildenbeest, J., Rebers, S. P. H., Phiri, K. S., Westerhuis, B. M., van Hensbroek, M. B., et al. (2018) · Archives of Virology · doi:10.1007/s00705-018-3878-7 · Cited by 21
Volle, R., Razafindratsimandresy, R., Joffret, M., Bessaud, M., Rabemanantsoa, S., Andriamamonjy, S., Raharinantoanina, J., Blondel, B., Héraud, J., Bailly, J., et al. (2019) · Journal of Virology · doi:10.1128/jvi.01667-18 · Cited by 22
“This may reflect the considerable diversity of EV-C types circulating in the population and the high frequency of intra- and intertypic recombination events (35, 36, 39).”
BackgroundSelf-citationAdeniji, J. A., & Faleye, T. O. C. (2014) · Journal of Virological Methods · doi:10.1016/j.jviromet.2014.07.016 · Cited by 22
Kapusinszky, B., Molnár, Z., Szomor, K. N., & Berencsi, G. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00621.x · Cited by 21
“In some cases, the recombination event occurred between vaccine and wild-type polioviruses (V/W) and/or nonpolio enteroviruses (Balanant et al., 1991; Guillot et al., 2000; Yang et al., 2005; Rakoto-Andrianarivelo et al., 2007).”
BackgroundSadeuh‐Mba, S. A., Kavunga‐Membo, H., Joffret, M., Riziki, Y., Endegue-Zanga, M. C., Bessaud, M., Njouom, R., Muyembé‐Tamfum, J., & Delpeyroux, F. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007335 · Cited by 18
“Data from the study of cVDPVs from Cambodia and Madagascar had already demonstrated that CV-A13, CV-A17 and possibly CV-A11 are efficient recombination partners of PVs [10, 20, 22, 23].”
BackgroundSelf-citationSmura, T., Blomqvist, S., Vuorinen, T., Ivanova, O. E., Samoilovich, E., Al‐Hello, H., Savolainen‐Kopra, C., Hovi, T., & Roivainen, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093737 · Cited by 18
“Previous reports have suggested low prevalence of EV-C viruses in temperate regions, whereas in tropical and sub-tropical regions EV-C viruses are highly prevalent [17,18,48–51].”
Razafindratsimandresy, R., Joffret, M., Andriamandimby, S. F., Andriamamonjy, S., Rabemanantsoa, S., Richard, V., Delpeyroux, F., Héraud, J., & Bessaud, M. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07826-0 · Cited by 15
“Discussion Previous studies have described the frequent presence of NPEVs in Madagascar and underlined the high frequency of EVs of species C [5, 25, 35].”
BackgroundResultSelf-citationLinsuwanon, P., Payungporn, S., Suwannakarn, K., Chieochansin, T., Theamboonlers, A., & Poovorawan, Y. (2011) · Virology Journal · doi:10.1186/1743-422x-8-5 · Cited by 17
“This results in a limited set of capsid genes responsible for HEV serotypes [44,46-48].”
BackgroundZhang, Y., Zhang, F., Zhu, S., Chen, L., Yan, D., Wang, D., Tang, R., Zhu, H., Hou, X., An, H., et al. (2009) · Archives of Virology · doi:10.1007/s00705-009-0564-9 · Cited by 15
“cVDPVs have circulated for approximately 1 year in the Guizhou province of China [26], showing that recombination with HEV-C is not essential for OPV strains to become cVDPVs, while the recombination frequency suggests that genetic exchanges may allow poliovirus and HEV-C to evolve rapidly and to acquire functions tha…”
BackgroundReemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar
Razafindratsimandresy, R., Joffret, M.-L., Rabemanantsoa, S., Andriamamonjy, S., Heraud, J.-M., & Delpeyroux, F. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1906.130080 · Cited by 14
Self-citationKitamura, K., & Shimizu, H. (2021) · Viruses · doi:10.3390/v13071407 · Cited by 14
Odoom, J. K., Forrest, L., Dunn, G., Osei-Kwasi, M., Obodai, E., Arthur-Quarm, J., Barnor, J. S., Minor, P. D., & Martín, J. E.-S. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis474 · Cited by 15
Defining the Enterovirus Diversity Landscape of a Fecal Sample: A Methodological Challenge?
Faleye, T. O. C., Adewumi, M. O., & Adeniji, J. A. (2016) · Viruses · doi:10.3390/v8010018 · Cited by 17
“In fact, studies [51–58] have shown that the difference in the transmissibility and pathogenicity between two revertant Sabin-like polioviruses might be as simple as the origin of the non-structural region they each possess.”
ResultHorsington, J. J., Gilkerson, J. R., & Hartley, C. A. (2010) · Virus Research · doi:10.1016/j.virusres.2010.12.007 · Cited by 13
Emergence of Vaccine-Derived Polioviruses during Ebola Virus Disease Outbreak, Guinea, 2014–2015
Fernández-García, M. D., Majumdar, M., Kébé, O., Fall, A. D., Kone, M., Kande, M., Dabo, M., Sylla, M. S., Sompare, D., Howard, W., et al. (2017) · Emerging infectious diseases · doi:10.3201/eid2401.171174 · Cited by 14
Lu, J., Zheng, H., Zhang, Y., Guo, X. Y., Wu, D., Li, H., Liu, L., Zeng, H., Yi, L., Fang, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086877 · Cited by 12
“All enteroviruses contain a genome of approximately 7,500 bases and are known to have a high mutation rate due to low-fidelity replication and frequent recombination [7,8,9].”
BackgroundDelpeyroux, F., Colbère-Garapin, F., Razafindratsimandresy, R., Sadeuh-Mba, S., Joffret, M.-L., Rousset, D., & Blondel, B. (2013) · médecine/sciences · doi:10.1051/medsci/20132911021 · Cited by 11
“Il n’est pas possible, à l’heure actuelle, d’exclure totalement l’hypothèse selon laquelle la recombinaison intertypique chez les HEV-C serait une conséquence 2 Un virus recombinant intratypique est le produit de la recombinaison entre deux ou plusieurs virus de même sérotype (par exemple : PV souche sauvage de type 1…”
BackgroundInfluentialSelf-citationLizasoain, A., Burlandy, F. M., Victoria, M., Tort, L. F. L., da Silva, E. E., & Colina, R. (2018) · Food and Environmental Virology · doi:10.1007/s12560-018-9351-7 · Cited by 10
Fernández-García, M. D., Faye, M., Díez‐Fuertes, F., Moreno‐Docón, A., Chirlaque-López, M. D., Faye, O., & Cabrerizo, M. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1168355 · Cited by 9
“Vaccine/non-vaccine breakpoints in the genomes of recombinant VDPVs are usually located at the end of the 2A- or 2B-coding sequences, although they may also be found close to the vaccine/non-vaccine junction or in the P3 region (Rakoto-Andrianarivelo et al., 2007; Bessaud et al., 2016; Faleye et al., 2019; Joffret et…”
BackgroundResultInfluentialJunttila, N., Lévêque, N., Magnius, L. O., Kabue, J. P., Muyembe‐Tamfum, J. J., Maslin, J., Lina, B., & Norder, H. (2014) · Journal of Medical Virology · doi:10.1002/jmv.24062 · Cited by 9
“DOI 10.1002/jmv structural region, since most recombination events in the coding region occur within P2 [Lukashev et al., 2005; Simmonds and Welch, 2006; Mirand et al., 2007; Rakoto-Andrianarivelo et al., 2007].”
BackgroundInfluentialA Transgenic Mouse Model of Poliomyelitis
Koike, S., & Nagata, N. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3292-4_7 · Cited by 9
Băicuş, A., Persu, A., Dinu, S., Joffret, M., Delpeyroux, F., & Oprişan, G. (2011) · Archives of Virology · doi:10.1007/s00705-010-0895-6 · Cited by 9
“The three serotypes of PV belong to HEV-C.”
BackgroundResultInfluentialSelf-citationKITAMURA, K., & Shimizu, H. (2022) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2022.312 · Cited by 7
Ivanova, O. E., Kozlovskaya, L. I., Eremeeva, T. P., Shakaryan, A. K., Ap, I., Baykova, O. Y., Krasota, A. Y., Shustova, E. Y., Mustafina, A. N., Morozova, N. S., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.09.034 · Cited by 7
Bessaud, M., & Delpeyroux, F. (2012) · Journal of Virological Methods · doi:10.1016/j.jviromet.2012.08.001 · Cited by 7
Self-citationCouderé, K., Benschop, K., van Steen, A., Verweij, J. J., Pas, S. D., Cremer, J., Edridge, A. W. D., Abd‐Elfarag, G., van Hensbroek, M. B., Pajkrt, D., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29194 · Cited by 6
Razafindratsimandresy, R., Mach, O., Héraud, J., Bernardson, B., Weldon, W. C., Oberste, M. S., & Sutter, R. W. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00563 · Cited by 7
“VDPV outbreaks usually occur in areas of low population immunity to polioviruses; in addition, there have been suggestions that the presence of other enteroviruses in the environment, particularly the high prevalence of species C was linked to emergence of VPDVs in Madagascar [6].”
BackgroundPoliovirus et entérovirus C, même espèce, même « tribu » virale
Andrianarivelo, M. R., Jégouic, S., Bessaud, M., & Delpeyroux, F. (2008) · médecine/sciences · doi:10.1051/medsci/2008245452 · Cited by 6
Self-citationLiu, J., Zhang, H., Zhao, Y., Xia, L., Guo, C., Yang, H. F., Luo, N., He, Z., & Ma, S. (2016) · Virology Journal · doi:10.1186/s12985-016-0615-2 · Cited by 5
“There were many reports of AFP cases caused by VDPV3 [10–12, 20–22], but AFP caused by VRPV3 has rarely been reported.”
BackgroundDevelopment of picornavirus-like particle vaccines
Somasundaram, B., & Lua, L. H. L. (2015) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.14.39 · Cited by 4
Hilgenfeld, R. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.211 · Cited by 3
Isolation and characterization of a highly evolved type 3 vaccine-derived poliovirus in China
Zhang, X., Qin, C., Li, W., Zheng, Z., Wang, H., & Cui, Z. (2017) · Virus Research · doi:10.1016/j.virusres.2017.06.017 · Cited by 3
Role of Non-Polioviruses in Acute Flaccid Paralysis (AFP)
Abbasian, F., Saberbaghi, T., & Moosapour, A. (2012) · Journal of Gastroenterology and Hepatology Research · Cited by 6
Enhanced Gene Silencing in Cells Cured of Persistent Virus Infection by RNA Interference
Pelletier, I., Saulnier, A., Brisac, C., Jégouic, S., Vabret, N., Tangy, F., Blondel, B., & Colbère-Garapin, F. (2010) · Journal of Virology · doi:10.1128/jvi.02060-09 · Cited by 3
“Virus silencing was also investigated in cured cells infected with Sabin 2 or coxsackievirus A17 (CAV17) strain 67591 (22) or in cells transfected with Sabin 2 RNA.”
BackgroundSelf-citationThe lost decade of Global Polio Eradication and moving forward
Shimizu, H. (2010) · Uirusu · doi:10.2222/jsv.60.49 · Cited by 3
A novel Enterovirus 96 circulating in China causes hand, foot, and mouth disease
Xu, Y., Sun, Y., Ma, J., Zhou, S., Fang, W., Ye, J., Tan, L., Ji, J., Luo, D., Li, L., et al. (2017) · Virus Genes · doi:10.1007/s11262-017-1431-5 · Cited by 3
Poliovirus serotype 2 and coxsackievirus A promote the natural recombination of poliovirus
Qian, Y., Pu, X., Yu, Y., Yu, X., Kong, L., Liu, L., Wang, H. X., & Shen, H. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25620 · Cited by 4
“recombinants had a high level of diversity and emerged from an EV‐C viral ecosystem, evolving through intratypic and intertypic recombination.(17,26,27) In this outbreak, PV3 was also isolated, giving the possibility that a widely circulating EV‐C with a recombinant 3′ end, served as an intermediate virus that produce…”
BackgroundModiyinji, A. F., Joffret, M., Sadeuh‐Mba, S. A., Ait‐Ahmed, M., Knowles, N. J., Njouom, R., ZANGA, M.-C. E., & Bessaud, M. (2025) · Archives of Virology · doi:10.1007/s00705-025-06296-4 · Cited by 4
“Previous studies have documented that the use of the HEp-2c cell line greatly increases the isolation rate of EV-Cs [ 11– 13], which are relatively abundant in sub-Saharan Africa and in Madagascar compared to other geographical regions.”
Penetration of baculoviruses into cell: Universal mechanism and intriguing details
Kikhno, I. M. (2009) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416809020013 · Cited by 2
Molecular Analysis of Enterovirus C Species Using the 5’ Untranslated Region and VP1 Region
Zhou, F. (2015) · Journal of Human Virology & Retrovirology · doi:10.15406/jhvrv.2015.02.00038 · Cited by 1
“The PVs are distinct from most of other members in EV-C only in the capsid region, suggesting that recombination has played a major role in their evolution [29,30,38].”
BackgroundInfluentialWilton, T. (2012) · doi:10.25560/10677 · Cited by 1
Bero, D. M. (2012) · Arca - Repositório Institucional da Fiocruz
Molecular Analysis of Enteroviruses
Zhou, F. (2016) · Journal of Human Virology & Retrovirology · doi:10.15406/jhvrv.2016.03.00083
“Studies have shown that, compared with VP1, the 5’ UTR of CV-A (sero)types and PVs has frequently been subject to recombination [17,145], indicating that interserotypic recombination may play a major”
BackgroundFirst Identification of Member of a New Coxsackievirus A16 Genetic Group in Senegal
Faye#, M., Barry#, M. A., Sall, Y., Ndiaye, N., Fall, C., Diallo, B., Kébé, O., Dieye, Y., Loucoubar, C., Diop, B., et al. (2024) · Annals of Case Reports · doi:10.29011/2574-7754.101835
“While many recombinant EV have been reported in isolates derived from vaccine polioviruses and co-circulating EV-C viruses [91,99], only few examples of recombinant EV-A viruses have been previously described [100-102].”
BackgroundSauthier, J. T., Dias, J. B., Ferreira, C. D. S., Gomes, B. D. O. N., Fraga, K. A., Gonçalves, I. M. D. S., de Souza, A. A. A., dos Santos, A. A. C., Müller, B. D. L. A., Lima, L. F., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5180131
Zhang, W. Y., Yan, D., Zeng, H., Zhou, L., Zheng, H., Zhu, S., Zhang, Y., & Li, B. (2025) · Virology Journal · doi:10.1186/s12985-025-02827-2
Tinard, A., Joffret, M., Levert, M., Wurtzer, S., & Bessaud, M. (2025) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/traf090
Morobe, J. M., Ong’era, E. M., Lambisia, A. W., Odoyo, S. O., Mutunga, M. N., Katama, E. N., Cheruiyot, R., Nyiro, J. U., Kamau, E., Houldcroft, C. J., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014589
“Sequencing demonstrated that the P2 (2A, 2B and 2C) and 3D pol regions of these cVDPV were derived from circulating CVA17 and CVA13 strains, with sustained recombination signals persisting through 2005 involving CVA13, CVA17, and possibly CVA11 [48–50].”
Metadata
- Authors
- Rakoto-Andrianarivelo, M., Guillot, S., Iber, J., Balanant, J., Blondel, B., Riquet, F., Martin, J., Kew, O., Randriamanalina, B., Razafinimpiasa, L., Rousset, D., & Delpeyroux, F.
- Affiliations
- Institut Pasteur (FR)
- Centers for Disease Control and Prevention (US)
- Centre Pasteur du Cameroun (CM)
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-12-14
- Volume
- 3
- Issue
- 12
- Pages
- e191
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2134956
- OpenAlex
- W2119910918
- Cited by
- 96
- References
- 76
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 9 · 2015: 7 · 2014: 6 · 2013: 7 · 2012: 11
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- vaccine-derived poliovirus, poliovirus type 2, co-circulation, viral recombination, acute flaccid paralysis, echovirus, neurovirulence, poliovirus evolution, viral diversity, Madagascar
- MeSH terms
- Animals, Cells, Cultured, Disease Outbreaks, Feces, Female, Humans, Madagascar, Male, Paralysis, Poliovirus Vaccine, Oral, Recombination, Genetic, RNA, Viral, Serotyping, Genome, Viral, Molecular Epidemiology, Poliovirus, Evolution, Molecular, Genomics, Enterovirus C, Human, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.